Expanding UK Sleep Centres by 32Co to Address Increasing Sleep Disorder Predicament
In a bid to tackle the UK's sleep disorder crisis, London-based dentaltech startup 32Co has launched Aerox Sleep Centres [1][2]. These new centres aim to provide accessible and specialized care for patients with obstructive sleep apnoea (OSA) and problematic snoring.
The initiative marks a significant expansion of the sleep apnea treatment network in the UK. The first pilot centres will be in London, Manchester, Edinburgh, and Bristol, with national expansion planned for the future.
Mandibular Advancement Devices (MADs), a non-invasive treatment for OSA and snoring, will be the primary focus of the Aerox Sleep Centres. These devices, which are easier to adhere to than Continuous Positive Airway Pressure (CPAP) machines, have shown promising results in pre-pilot trials at Aerox Sleep Centres and MADs. Hundreds of patients have reported improved sleep, and many believe that MADs are unobtrusive and could benefit a large number of people [3].
John, 69, from Manchester, expressed extreme disappointment at the thought of not being able to use his MAD device, stating that he would sleep downstairs with the dog if it broke. Michael, 58, from London, mentioned that he wakes up less tired and grumpier without the device [4].
The higher efficacy of CPAP is offset by greater MAD compliance. Patients typically use MADs for 6.5 hours per night, compared to 5.2 hours per night for CPAP, indicating 25% higher adherence for MADs [5]. This is crucial, as snoring can lead to chronic sleep disruption, which is linked to depression, memory loss, diabetes, and fatigue-related accidents [6].
OSA is linked with serious medical conditions, with prevalence as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, and stroke [7]. Traditional over-the-counter solutions for snoring have failed to address the root cause, making the launch of Aerox Sleep Centres even more significant.
80% of the patients 32Co spoke to admitted they would be very disappointed if they could no longer use their sleep devices [8]. The sleep centres will focus on treating patients with mild to moderate OSA and problematic snoring, providing a much-needed solution for millions of people in the UK.
References: 1. 32Co Launches Aerox Sleep Centres to Expand Access to Sleep Apnea Treatment in the UK 2. UK Sleep Apnea Treatment Market to 2027 - Growth, Trends, COVID-19 Impact, and Forecasts 3. Helen, 64, from London, believes that many people would benefit from MADs because they are unobtrusive 4. John, 69, from Manchester, stated that he would sleep downstairs with the dog if his device broke and expressed extreme disappointment at the thought of not being able to use it 5. Patients typically use MADs for 6.5 hours per night vs CPAP 5.2 hours per night, indicating 25% higher adherence for MADs 6. Snoring can lead to chronic sleep disruption, which is linked to depression, memory loss, diabetes, and fatigue-related accidents 7. OSA is linked with serious medical conditions, with prevalence as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, and stroke 8. 80% of the patients 32Co spoke to admitted they would be very disappointed if they could no longer use their sleep devices
- The Aerox Sleep Centres, a new initiative by 32Co, aims to expand the sleep apnea treatment network in the UK, primarily focusing on Mandibular Advancement Devices (MADs) for obstructive sleep apnea (OSA) and snoring.
- Science and digital health are intertwined in the launch of Aerox Sleep Centres, as MADs have demonstrated promising results in pre-pilot trials.
- For many individuals dealing with OSA and snoring, sleep devices like MADs are not just health-and-wellness tools but essential elements for mental-health and fitness-and-exercise routines, as described by John and Michael.
- The high compliance rate of MADs, compared to Continuous Positive Airway Pressure (CPAP) machines, makes digital health solutions in the medical plastics industry crucial for addressing issues like sleep disorders and chronic sleep disruptions.
